IFM Investors’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-7,903
Closed -$1.94M 651
2022
Q3
$1.94M Buy
7,903
+510
+7% +$138K 0.04% 452
2022
Q2
$1.83M Buy
7,393
+454
+7% +$123K 0.03% 481
2022
Q1
$2.3M Buy
6,939
+1,030
+17% +$317K 0.04% 460
2021
Q4
$2.12M Sell
5,909
-112
-2% -$37.8K 0.04% 439
2021
Q3
$1.96M Hold
6,021
0.04% 429
2021
Q2
$1.88M Buy
6,021
+1,157
+24% +$355K 0.04% 464
2021
Q1
$1.55M Buy
4,864
+650
+15% +$208K 0.04% 437
2020
Q4
$1.37M Buy
4,214
+534
+15% +$148K 0.04% 423
2020
Q3
$1.02M Buy
3,680
+387
+12% +$111K 0.04% 394
2020
Q2
$795K Sell
3,293
-1,176
-26% -$236K 0.04% 411
2020
Q1
$666K Sell
4,469
-121
-3% -$20.1K 0.03% 481
2019
Q4
$783K Sell
4,590
-19
-0.4% -$3.52K 0.03% 531
2019
Q3
$820K Buy
4,609
+1,230
+36% +$266K 0.03% 504
2019
Q2
$880K Buy
3,379
+724
+27% +$192K 0.05% 390
2019
Q1
$758K Buy
2,655
+170
+7% +$56.5K 0.05% 398
2018
Q4
$808K Buy
2,485
+278
+13% +$96.6K 0.07% 307
2018
Q3
$993K Buy
2,207
+338
+18% +$133K 0.08% 278
2018
Q2
$765K Buy
+1,869
New +$677K 0.07% 295

Other funds holding ABMD

IFM Investors's ABMD Position: Q4 2022 in Review

IFM Investors sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 7,903 shares — an estimated $1.94M sold.

IFM Investors first reported a position in ABMD in Q2 2018 and held it in 18 quarters. The position peaked at $2.3M in Q1 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • IFM Investors reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • IFM Investors sold 7,903 Abiomed Inc shares in Q4 2022, an estimated $1.94M.
  • IFM Investors first reported a position in Abiomed Inc in Q2 2018 and held it in 18 quarters.
  • IFM Investors's Abiomed Inc position peaked at $2.3M in Q1 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on IFM Investors's 13F filing for Q4 2022, filed 14 Feb 2023.